Risk factors for the development of cataract requiring surgery in uveitis associated with juvenile idiopathic arthritis.
OBJECTIVE
To identify the possible risk factors for the development of cataract requiring surgery in children with juvenile idiopathic arthritis (JIA)-associated uveitis.


METHODS
Retrospective cohort study.


METHODS
Data of 53 children with JIA-associated uveitis, of whom 27 had undergone cataract extraction (CE), were obtained. The main outcome measure, the interval between the onset of uveitis and the first CE (U-CE interval), was examined in relation to clinical and ophthalmologic characteristics and treatment strategies before CE.


RESULTS
A shorter U-CE interval was found for children with posterior synechia vs those without posterior synechia (hazard ratio [HR], 3.57; 95% confidence interval [CI], 1.33 to 10.00). No significant difference was found for children in whom the uveitis was the first manifestation of JIA vs those in whom arthritis was the first manifestation of JIA (HR, 1.59; 95% CI, 0.63 to 4.00) and children treated with periocular corticosteroid injections vs those not treated with periocular corticosteroid injections (HR, 3.23; 95% CI, 0.95 to 11.11). Children treated with methotrexate (MTX) had a longer U-CE interval than children not treated with MTX (HR, 0.29; 95% CI, 0.10 to 0.87).


CONCLUSIONS
The risk factor for development of early cataract requiring surgery in children with JIA-associated uveitis is the presence of posterior synechia at the time of diagnosis of uveitis. However, early treatment with MTX is associated with a mean delay in the development of cataract requiring surgery of 3.5 years.
Sijssens
Karen M
KM
FC Donders Institute of Ophthalmology, University Medical Center Utrecht, Utrecht, The Netherlands. K.Sijssens@umcutrecht.nl
Rothova
Aniki
A
Van De Vijver
David A M C
DA
Stilma
Jan S
JS
De Boer
Joke H
JH
D017668:Age of Onset; D001171:Arthritis, Juvenile / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D002386:Cataract / Q000209:etiology* / Q000628:therapy; D002387:Cataract Extraction; D002648:Child; D002675:Child, Preschool; D002908:Chronic Disease; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D012189:Retrospective Studies; D012307:Risk Factors; D014605:Uveitis / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy
D005938:Glucocorticoids; D007166:Immunosuppressive Agents